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hat  is  your  diagnosis?athology  of  the  cervical  esophagus
.-A.  Righini ∗, A.  Coffre
ôle TCCR, hôpital nord Michallon, clinique universitaire d’ORL, CHU de Grenoble, CS 10217, 38043 Grenoble cedex 9, France. Description
A 53-year-old man  with ongoing history of smoking (35 pack-
ears) and alcohol consumption (2 IU/day) consulted for left
haryngeal discomfort with occasional sensation of dysphagia
ithout odynophagia or reﬂex otalgia. General health status was
onserved: weight stable at 73 kg; height, 1.78 m.  Oral cavity exam-
nation was normal apart from poor dental status: widespread
ecay, diffuse parodontopathy. Flexible nasal endoscopy found no
haryngolaryngeal mucosal abnormality, and the vocal folds were
obile. In view of the context, contrast-enhanced CT of the oral
avity, pharyngolarynx, neck and chest was performed, and found
o abnormalities. Rigid endoscopy under general anesthesia was
hen performed, and found no suspect mucosal lesions of the oro-
ypopharynx or larynx. Palpation of the palatine tonsils and base of
he tongue was normal. Rigid esophagoscopy up to 35 cm from the
ental arcades found a lesion of the right esophageal mucosa 2 cm
elow the mouth of the esophagus (Fig. 1a), which was biopsied for
istologic analysis (Fig. 1b: ×100, hematoxylin-eosin staining).
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879-7296/© 2014 Elsevier Masson SAS. All rights reserved.Fig. 1. a: endoscopic view; b: histologic analysis.What is your diagnosis?
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Histology (Fig. 1b) conﬁrmed heterotopic gastric mucosa (HGM)
n the fundus, without signs of degeneration, with superﬁcial
ucosal cells (*), inﬂammatory inﬁltrate with predominance of
ymphocytes (→), mainly localized in the lamina propria, and, more
eeply, islands of endocrine cells (o). The ﬁrst case of HGM was
eported by Schmidt in 1805, with esophageal location. HGM may
e located throughout the digestive tract, but the two most frequent
ites are Meckel’s diverticulum and the cervical esophagus, either
t or in the 3 cm below the mouth of the esophagus [1,2]. It usually
nvolves fragments of fundus or, more rarely, associated fundus and
ntrum mucosa, which may  be microscopic or visible to endoscopy
s so-called inlet patches of variable size [3]. Most reports have
ome from gastroenterologists. There are two forms of HGM: con-
enital or acquired. Acquired forms are located in the lower third of
he esophagus, in continuity with the Z line, and are better known as
arrett’s esophagus, thought to be scar mucosa induced by chronic
nﬂammation usually related to gastroesophageal reﬂux. It is gener-
lly considered that the congenital form develops from embryonic
esidue resulting from incomplete esophageal epithelialization [4],
lthough some authors relate it to gastroesophageal reﬂux. Etiol-
gy is thus uncertain. Exact prevalence is not known: in the earliest,
etrospective, studies, incidence was gender equivalent, between
 and 3.8%; more recent prospective studies by gastroenterolo-
ists focusing on HGM, however, reported prevalences of 10% [5].
acroscopically visible mucosal inlets range in size between 2 mm
nd several centimeters, and may  be single or multiple, of various
hapes. HGM is generally asymptomatic, and is usually detected
n digestive tract endoscopy performed for some other pathology;
cid secreted by parietal cells of the fundus mucosa may, however,
nduce inﬂammation and/or mucosal erosion leading to dysphagia,
dynophagia, bleeding, stenosis or, very exceptionally, perforation
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[2]. Mucosal degeneration in the form of adenocarcinoma is like-
wise very rare, with less than 30 cases reported in the literature
[2]. No treatment is necessary for incidental HGM, in whatever
location. In symptomatic forms, a proton pump inhibitor or H2
receptor antagonist should be prescribed. There is no consensus as
to treatment duration. In symptomatic stenosis, balloon inﬂation is
the reference attitude, with systematic biopsy of the stenotic area
to rule out neoplastic evolution [2]. In perforation, management
is not standardized, but there seems to be a certain consensus:
medical treatment (proton pump inhibitors) of non-standardized
duration, interruption of oral feeding, with endoscopic surgery if
necessary (using biologic glue or Argon plasma electrocoagulation)
for extrathoracic perforation; surgery using a mediastinal approach
for intrathoracic perforation, to avoid mediastinitis. In extratho-
racic perforation, evolution is generally favorable.
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